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ABSTRACT  
Background 
Escherichia coli is one of the most frequent causes of late-onset neonatal sepsis. The 
aim of this study was to characterize an outbreak of neonatal sepsis occurring in the 
neonatal intensive care unit (NICU) of the Hospital Clinic of Barcelona from April to 
August 2013. 
Methods  
After presentation of the index case, all E. coli isolates from previously hospitalized 
neonates, health care workers, and neonates admitted to the NICU from April to 
October 2013 were tested for K1 antigen positivity and epidemiologically compared by 
pulse-field gel electrophoresis. Furthermore, the E. coli K1 strains collected from 
neonates during this period were analyzed by different methods (serotyping, 
phylotyping, PCR of virulence factors, antimicrobial resistance, and “in vitro” assays in 
HMBEC).  
Results  
An E. coli O18:K1:H7 sequence type 95 and phylogenetical group B2 strain was the 
cause of the outbreak involving 6 preterm neonates: one with late septicemia due to a 
urinary focus and 5 with late-onset septicemia and meningitis, 3 of whom died. All 
showed the same pulsotype, full resistance to ampicillin and intermediate resistance to 
gentamicin. The outbreak strain carried the PAI IIJ96-like domain that could explain the 
high-grade bacteremia necessary to develop meningitis.  
Conclusions 
Abstract-revised
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All the E. coli isolates responsible for this outbreak belonged to a single clone 
suggesting a common source of infection, and it was categorized as O18:K1:H7. 
Despite the bacteria’s pathogenicity has an important role in the severity of infection, 
the host-associated factors were crucial for the fatal outcomes. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5 
 
INTRODUCTION  1 
Late-onset neonatal sepsis (LONS) is acquired after the first 72 hours of life and often 2 
leads to meningitis. Escherichia coli frequently causes septicemia and meningitis1. 3 
However, at present, the pathogenesis of meningitis caused by E. coli is only partially 4 
understood for two reasons: i) this infectious disease is a complex process formed by 5 
multiple bacterial-host interactions, and ii) the high genetic diversity of the pathotypes 6 
among neonatal meningitis E. coli (NMEC) strains.  7 
It is known that there are a few features that distinguish these strains. NMEC strains are 8 
part of the extraintestinal pathogenic E. coli (ExPEC) subgroup, most of which belong 9 
to phylogroup B22 and the sequence type (ST) 95 complex3. One of the most common 10 
serotypes is O18:K1:H74 to which two of the representative NMEC strains belong, C5 11 
and RS218. The K1 capsular antigen has frequently been detected among isolates 12 
causing septicemia and is also presented by approximately 80% of E. coli strains 13 
causing neonatal meningitis5. Type 1 fimbriae, S fimbriae, outer membrane protein A, 14 
cytotoxic necrotizing factor 1, invasion brain endothelial cell proteins, arylsulfatase-15 
like, and TraJ have been described as traditional virulence-associated factors involved in 16 
different stages of meningitis6–9. Some of these genes are usually located in clusters 17 
classified as “ectochromosomal DNA” (ECDNA)10, which can be horizontally 18 
transferred and hence, may be easily spread.  19 
The equilibrium between host defenses and the pathogenicity of the bacteria in terms of 20 
virulence and resistance determine the extent of bacterial infection and the outcome of 21 
the disease1. Prematurity, and consequently, low birth weight are risk factors for the 22 
development of septicemia and meningitis in neonates11, allowing these infections to be 23 
caused by “low-virulent” bacteria1. Neonatal intensive care units (NICUs) are sites in 24 
Manuscript-revised
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which infants are more prone to acquire nosocomial infections and are a focus of  25 
outbreaks, including diarrhea12 or meningitis13,14. For all these reasons, the identification 26 
of these pathogens is a challenge, especially if they present multi-drug resistance 27 
leading to a therapeutic failure. 28 
The aim of this study was to characterize an outbreak of neonatal sepsis occurring in the 29 
NICU at the Hospital Clinic of Barcelona from April to August 2013. 30 
MATERIALS AND METHODS 31 
Microbiologic examination 32 
Cerebrospinal fluid, urine and blood samples from the neonates involved in the outbreak 33 
were taken for microbiologic examination. In addition, 8 stool samples from health care 34 
workers (HCWs) and 29 from neonates admitted from April to October 2013 were 35 
included to evaluate the dissemination in the NICU and to find the possible cause of the 36 
outbreak. Stool samples were inoculated on MacConkey agar and incubated at 37ºC 37 
overnight. Suspected colonies were confirmed by MALDI-TOF. All E. coli isolates 38 
were tested for K1 antigen by the agglutination assay using a latex KIT (PASTOREX 39 
Meningitis Kit, Bio-Rad). The isolates that were positive were confirmed using specific 40 
primers for neu-PCR, which amplify the neuraminidase locus identified as a specific K1 41 
target15. Furthermore, the same PCR was performed in 42 E. coli isolates from pharynx 42 
and otic smears, blood cultures and one urine culture positive from neonates 43 
hospitalized from January 2011 to April 2013. 44 
Analysis of chromosomal DNA by Pulse-Field Gel Electrophoresis (PFGE) 45 
Bacterial suspensions were prepared and embedded in agarose following a previous 46 
protocol with slight modifications16. PFGE of the strains was performed using XbaI as 47 
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the restriction enzyme. One % agarose gel was run on a CHEF-Mapper contour-48 
clamped homogenous electric field apparatus for 20 h at 200 V (initial switch time 5 s, 49 
final switch time 35 s). The cluster analysis was performed with InfoQuest-FP software 50 
using the Dice similarity coefficient and dendrogram type UPGMA (unweighted-pair 51 
group method with arithmetic mean using average linkages) (optimization 0.50%, 52 
position tolerance 1.50%). A value of more than 95% of band similarity was considered 53 
as the same clone. 54 
Strains 55 
The strains selected to perform the different assays were the strain N38 belonging to the 56 
outbreak and other four K1-positive E. coli strains collected during the same period: 57 
N36 and N39, which were collected from healthy colonized neonates; N40, which 58 
caused an infection in a mother leading a fetal death; and N49, which was collected 59 
from a neonate suffering late-onset sepsis.  60 
Multilocus sequence typing (MLST)  61 
This study used the MLST scheme for E. coli developed by Wirth et al.17. Allele 62 
sequences were analyzed with a database available online 63 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). 64 
Phylogenetic analysis 65 
The new phylo-typing method by Clermont at al.18 with several modifications19 was 66 
used to assign the E. coli isolates to the eight phylogroups (B2, D, B1, A, E, Non-67 
typeable, F, C, and E clade 1).  68 
“In vivo” killing assay with Caenorhabditis elegans 69 
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Killing assays were performed in C. elegans according to a previously described 70 
model20 but using Luria Broth (LB) instead of brain heart infusion medium. Each strain 71 
was repeated more than 5 times using E. coli OP50 as the internal control. Lethal Time 72 
50% (LT50) is the number of days required to kill 50% of the nematode population.  73 
Mass spectrometric sequencing of protein silver-stained polyacrylamide gels  74 
The total proteome of N36 and N38 was analyzed using 2D gel electrophoresis followed 75 
by mass spectrometric identification as previously described by Párraga et al.21. 76 
RNA sequencing 77 
RNA extraction was performed as described elsewhere22. rRNA depletion was done 78 
with the Ribo-ZeroTM Magnetic Kit for Gram-negative bacteria. The TruSeq Stranded 79 
mRNA Sample Prep Kit protocol was followed according manufacturer’s instructions. 80 
Libraries were validated by qPCR with Kapa Paired end and 75 nt read length libraries 81 
were sequenced on an Illumina Miseq resulting in a total output of 38 million reads. An 82 
average Phred quality score of 37 was obtained for the average of 3.1 million reads per 83 
sample. Reads were mapped onto the reference genome (E. coli O7:K1 str. CE10, 84 
complete genome (NC_017646) and its associated plasmids, E.coli O7:K1 str. CE10 85 
plasmid pCE10A (NC_017647), pCE10B (NC_017648), pCE10C (NC_017649) and 86 
pCE10D(NC_017650)) using the EDGEpro software23. Resulting count datasets were 87 
exported to DESeq224, where they were normalized and pair-wise differential 88 
expression was carried out. Genes below p 0.05 were considered significant and used 89 
for Gene Ontology and Pathway analysis conducted by David25. 90 
Real-Time PCR experiments 91 
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RNA extraction was performed as mentioned above in RNA sequencing, and the Real-92 
time PCR reactions were carried out following the same protocol22. For the RT-PCR, 93 
500 ng of each RNA sample was used to make the reverse transcription, and the cDNA 94 
template was diluted 1/5. On one hand, the genes selected were those overexpressed in 95 
N38 compared to N36 by RNA-seq. These genes included: rfaI, rfaL, rfaP, rfaY, waaT, 96 
waaV, waaW (all involved in lipopolysaccharide biosynthesis of E. coli), papI1 97 
(encoding the pyelonephritis adhesin pili operon regulatory protein PapI) and, fliD and 98 
fliC (involved in flagellar assembly). On the other hand, other genes were considered 99 
relevant because of the functions of their products. These genes were: neuC (encoding 100 
the polysialic acid biosynthesis of the K1 capsule), kpsC and kpsD (encoding capsule 101 
polysaccharide transport proteins), fimD (encoding a type-1 fimbria), ompA (encoding 102 
an outer membrane protein), and aslB, ibeB, ibeC (encoding virulence factors associated 103 
with meningitis). 16S rRNA was used as the endogenous control. Primers to amplify 104 
these genes were the same as those used in previous studies or designed by Primer 105 
Express® software (see Table, Supplemental Digital Content 1). The optimal 106 
concentration of the primers was from 2 to 9 µM after several assays. Amplification was 107 
performed using a StepOne™ Real-Time PCR System using the Sybr Premix Ex Taq 108 
”Tli RNaseH Plus” kit and the Universal Thermal Cycling conditions: 2 min at 50ºC, 10 109 
min at 95ºC followed by 40 cycles of 95 ºC for 15 s and 60 ºC for 1 min. Data were 110 
analyzed with StepOne software v2.0, and the relative expression level for each sample 111 
(2-∆∆CT) was obtained. 112 
Detection of virulence factor genes (VFGs)  113 
The virulence profile was analyzed by PCR using gene-specific primers (see Table, 114 
Supplemental Digital Content 2) as described elsewhere26. Twenty-three genes were 115 
studied: hemolysin (hlyA), cytotoxic necrotizing factor (cnf1), autotransporter toxin 116 
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(sat1), P-fimbriae (papA, -EF, -C), type-1 fimbriae (fimH), type 1-C fimbria (focG), S-117 
fimbriae (sfa/foc and sfaS), yersiniabactin (fyuA), siderophores (iutA and iroN), 118 
aerobactin (iucC), invasion of brain endothelium factors (ibeA and ibeC), two genes 119 
involved in meningitis (aslA and traJ) and heat-resistant agglutinin (hra). Additionally, 120 
a PCR was performed to detect the PAI IIJ96-like domain. 121 
Adherence and invasion assays in human brain microvascular endothelial cells 122 
(HBMEC) 123 
A HMBEC line was grown in endothelial cell medium, supplemented with 5% of fetal 124 
bovine serum (FBS), 1% of endothelial cell growth factors and 1/100 dilution of 125 
penicillin/streptomycin solution (10000 units-10 mg/mL). HMBEC were seeded onto 126 
24-well tissue culture plates at a density of 2.5 x105 cells. Bacterial cultures incubated 127 
overnight in LB at 37º without shaking were used to infect each plate at a multiplicity of 128 
infection of approximately 100. Adherence and invasion assays were performed 129 
following a previously described protocol27. The only modification was the use of 130 
gentamicin (100 mg/mL) or kanamycin (50 mg/ml) for the invasion assay depending on 131 
the strain’s antimicrobial susceptibility. All experiments were run in duplicate on at 132 
least three different days. 133 
Serotyping 134 
Serotyping was performed in the Federal Institute for Risk Assessment (BfR) at the 135 
National Reference Laboratory for E. coli in Berlin, Germany. The Orksov28 [28] and 136 
Ewing29 protocols were used. 137 
Antibiotic susceptibility testing 138 
Minimal inhibitory concentrations were determined using E-test strips on Müeller-139 
Hinton agar plates inoculated with 0.5 MacFarland densities. Susceptibility was tested 140 
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for the following antimicrobial agents: ampicillin (AMP), amoxicillin-clavulanic acid 141 
(AMC), piperacillin-tazobactam (TZP), cefotaxime (CTX), meropenem (MEM), 142 
tetracycline (TET), trimethoprim-sulfamethoxazole (SXT), gentamicin (GEN), 143 
amikacin (AK), kanamycin (KAN), nalidixic acid (NA), ciprofloxacin (CIP), and 144 
fosfomycin (FOF). The ATCC 25922 strain was used as a standard control and results 145 
were analyzed according to the 2014 CLSI guidelines30.  146 
Biofilm assay  147 
Biofilm formation was detected using a previous protocol described by Merrit et al.31. 148 
The result was considered positive when absorbance was greater than 4-fold the value 149 
of the absorbance of the negative control. 150 
RESULTS 151 
Outbreak description 152 
The index case was a 7-day-old female neonate with a gestational age and birth weight 153 
of 29.2 weeks and 1,000 g, respectively. The neonate presented LONS the 13th of April 154 
2013, in addition to meningitis and intraventricular hemorrhage (IVH)-Grade II (Table 155 
1). Five more cases were detected thereafter. All were preterm neonates: one had late 156 
septicemia from a urinary focus, and 4 presented late onset septicemia and meningitis 157 
with severe neurological sequelae leading to death in three. The gestational age and 158 
birth weight of the neonates ranged from 25.2 to 29.2 weeks and from 750 to 1,000 g, 159 
respectively. The neonates also had other pathologies such as different grades of hyaline 160 
membrane disease, necrotizing enterocolitis and central nervous system hemorrhage. 161 
Due to AMP and GEN resistance, the treatment was CTX, CTX + AK, MEM + CIP or 162 
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MEM + AK according to the case. The length of the outbreak was 5 months, from April 163 
to August 2013 (Table 2). 164 
Characterization of the strain causing the outbreak  165 
An E. coli O18:K1:H7 strain was the cause of the outbreak. In epidemiological terms, 166 
the sequence type of the outbreak strain was ST95 (ST95 complex) and it belonged to 167 
phylogroup B2. In addition, this strain carried the PAI IIJ96-like (containing the hlyA, 168 
cnf1 and hra genes) and the PAI III536-like (containing the sfa/foc and iroN genes) 169 
domains. As for antimicrobial resistance, this strain showed full resistance to ampicillin, 170 
amoxicillin-clavulanic acid, tetracycline, and fosfomycin, and intermediate resistance to 171 
gentamicin.  172 
Comparative study with other K1-positive E. coli counterparts  173 
One (12.5%) and 5 (17.2%) isolates were found to be K1 antigen positive among 8 and 174 
29 E. coli isolates from the HCWs and neonates hospitalized during the study period, 175 
respectively. The prevalence of this antigen was 23.8% (10/42) among the neonates 176 
hospitalized from January 2011 to October 2013. PFGE was performed in all K1-177 
positive E. coli isolates resulting in 2 well differentiated clusters and 7 E. coli isolates 178 
were considered to be from the same clone due to 98.58% of band profile similarity. Six 179 
isolates were recovered from the symptomatic neonates belonging to the outbreak, while 180 
one was from an asymptomatic neonate who was hospitalized in the NICU at the time 181 
of the outbreak (Figure 1). All the E. coli isolates causing the outbreak belonged to 182 
phylogroup B2 as did most of the other strains analyzed. Only 2 strains belonged to the 183 
F phylogenetic group. 184 
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Besides the strain recovered from the outbreak case (N38), another K1-positive strain 185 
isolated from a healthy colonized neonate during the same period (N36) was tested in 186 
the C. elegans infection assay (see Figure, Supplemental Digital Content 3). Both 187 
clinical isolates showed a significant difference (p-value<0.0001) in virulence regarding 188 
the mean of survival compared with the avirulent E. coli OP50 control strain. The LT50 189 
was five versus eight days. However, no significant differences were found between 190 
N36 and N38. Neither was any significant differences found in the sequencing of 191 
proteins. 192 
RNA-seq analysis was performed in order to investigate the differences in gene 193 
expression profiles between strains N36 and N38. One hundred eight genes were 194 
differentially expressed between the strains (see Table, Supplemental Digital Content 4 195 
for a complete list of these genes), with the expression levels of 68 genes being more 196 
than three-fold higher in strain N38 than its counterpart N36, specifically, in relevant 197 
genes related to lipopolysaccharide biosynthesis, virulence and flagellar assembly 198 
(Table 3). In addition to the previous strains (N36 and N38), 3 more K1-positive strains 199 
(N39, N40 and N49) collected during the same period (April to October 2013) were 200 
selected to confirm the expression of several genes (Table 4). In this case, only 3 genes 201 
were overexpressed in the outbreak strain compared to the others: 2 genes associated 202 
with lipopolysaccharide biosynthesis (rfaI and rfaL) and the papI1 gene which encodes 203 
for a regulator protein of the pap operon, showing significant overexpression.  204 
Regarding the VFGs, the outbreak strain carried S-fimbriae (sfa/foc and sfaS) and the 205 
PAI IIJ96-like domain that were not present in the other K1 strains (Table 5). 206 
Strains N38 and 40 showed a higher capacity of adhesion than the other strains (Figure 207 
2A) whereas strain N39 was the most invasive of the HBMECs (Figure 2B). 208 
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All the isolates belonging to the outbreak showed multi-drug resistance having identical 209 
susceptibility patterns as those mentioned above (see Table, Supplemental Digital 210 
Content 5). Other strains also showed resistance to other antimicrobial agents. All the 211 
strains studied, including that causing the outbreak, had the ability to form “in vitro” 212 
biofilm. 213 
E. coli O18:H7 strains were recovered from the outbreak cases, whereas the other four 214 
strains (N36, N39, N40 and N49) were Or:H4 (Or means “rough” lipopolysaccharide), 215 
O2:H6, O75:[H5] ([Hxx] refers to H antigens listed by E&E in brackets), and O2:[H4], 216 
respectively.  217 
DISCUSSION 218 
This was the first outbreak of neonatal sepsis and meningitis at the NICU of the 219 
Hospital Clinic in Barcelona. An E. coli O18:K1:H7 sequence type 95 and phylogenetic 220 
group B2 strain was the cause of the outbreak involving six preterm neonates, one with 221 
late septicemia from a urinary focus and five with late septicemia and meningitis 222 
leading to death in three of them. All E. coli isolates from the outbreak were shown to 223 
belong to a single clone, suggesting a common source of infection.  224 
The prevalence of K1 antigen positivity among the E. coli isolates collected from the 225 
HCWs and neonates hospitalized at the Maternity was lower than that found among 226 
previously hospitalized neonates, a similar finding to what Sarff et al.32 described in a 227 
study carried out among healthy individuals but very low compared with another study 228 
performed in France33. 229 
The reason why the K1 capsule and only a few O-lipopolysaccharide antigens are 230 
associated with E. coli meningitis is still unclear, but their resistance properties allow 231 
these microorganisms to produce high-grade bacteraemia9. The outbreak strain belonged 232 
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to the serotype O18:K1:H7, which is one of the strains most frequently found among 233 
NMEC strains4,34. In addition, none of the serogroups from the other strains analyzed 234 
has been previously reported among E. coli causing neonatal meningitis. All the isolates 235 
belonged to phylogroups B2 and F, considered the most virulent among ExPEC isolates. 236 
Indeed, phylogroup B2 is commonly the most representative among NMEC 237 
isolates2,35,36. Likewise, ST95 is also frequent among ExPEC isolates and in particular 238 
those that cause neonatal meningitis37,38.  239 
Regarding the prevalence of VFGs by Real-Time PCR, the papI1 gene was 240 
overexpressed in the outbreak strain compared to the other genes. This is a 241 
transcriptional regulatory factor of the pap operon required in the P-fimbriae phase 242 
variation, a switch between the expression (Phase-ON) and the loss of expression 243 
(Phase-OFF) of these fimbriae. This is a regulatory complex that allows the cells to 244 
phenotypically change in response to environmental factors or other signals and 245 
represents an advantage for survival in hostile environments39. All the isolates including 246 
those belonging to the outbreak showed the genes encoding iron acquisition systems 247 
(fyuA, iutA, iroN, and iucC) which are necessary in iron-limited environments and 248 
relevant in septicemia and other extraintestinal infections11,40,41. In particular, the fyuA 249 
gene was present in all 11 representative NMEC strains used in a study performed by 250 
Yao et al.36. In contrast to the other strains, E. coli strains belonging to the outbreak 251 
carried the PAI IIJ96-like (hlyA, cnf1 and hra genes positive)
42 and the PAI III536-like 252 
(sfa/foc and iroN genes positive) domains43. These ECDNA-like domains, along with 253 
the possession of the ibeA gene, are very frequent among O18:K1 strains4 and are 254 
involved in the virulence of NMEC isolates but do not explain the whole pathogenesis 255 
of meningitis35. The PAI IC5, which is similar to the PAI IIJ96, and is harboured by strain 256 
C5, has been directly associated with bacterial survival in blood inducing high 257 
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bacteraemia but not with the passage of the bacteria across the blood-brain barrier44. As 258 
opposed to their counterparts, the outbreak strain possessed the hra gene, the presence 259 
of which is 91% homologous in uropathogenic E. coli strains compared to NMEC C5 260 
and RS218 strains45. Moreover, it is suspected that these two strains have developed an 261 
extraintestinal virulence specialization, such as uropathogenicity and meningitis, which 262 
has been helped by the genetic background of the clonal group O18:K135. There is 263 
controversy about the role of S fimbriae and Cnf1 in HMBEC binding or/and 264 
invasion9,44,46. These VFGs may have contributed to the higher ability of adhesion of the 265 
outbreak strain shown compared with their counterparts and other E. coli strains in other 266 
studies37,47. The only exception was strain N40, which caused infection in a mother 267 
leading to fetal death and showed the highest attachment of HMBEC. Strain N39 268 
showed the highest capacity to invade HMBEC, whereas strain N38 displayed the 269 
outstanding lowest frequency, which was very similar to that shown by the negative 270 
control E. coli K-12 HB101 in several assays37,48.  271 
Multi-drug resistance is a problem for the administration of adequate treatment. The 272 
outbreak strain showed full resistance to ampicillin and intermediate to gentamicin, with 273 
these antibiotics being the 1st line combination used to combat neonatal sepsis and 274 
meningitis. This results support that a change on the empiric regimen is needed in 275 
developed countries. Thus, cefotaxime could be used instead gentamicin due to the low 276 
percentages of resistance found among E. coli strains causing neonatal sepsis. In 277 
addition, all the strains were biofilm-producers, a feature which makes the pathogen 278 
more resistant and virulent49, especially when medical devices are used and may 279 
facilitate the transmission of colonizing microorganisms.  280 
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One three-month-old neonate developed urinary tract infection and septicemia but not 281 
meningitis. Age has been reported to be related to the achievement of the threshold level 282 
of bacteraemia required for the development of meningitis, but not for HMBEC binding 283 
and/or invasion50. At the time of the development of sepsis this neonate did not have a 284 
low weight and therefore likely presented a stronger immune system than the other 285 
neonates. Hence, a high bacterial inoculation might have been required to reach the 286 
necessary level of bacteraemia to develop meningitis. Features such as multi-drug 287 
resistance, capacity of biofilm-production, virulence-associated factors (PAI IIJ96-like 288 
and PAI III536-like domains), and pertinence to the O18:K1:H7 serotype, sequence type 289 
95, and phylogroup B2, may have been key factors for the strain to cause the outbreak. 290 
Nonetheless, the status of the immune system of the neonates and the lack of host 291 
defenses undoubtedly played a major role in the outcome of the disease. 292 
The method of transmission remained unclear, although mothers, HCWs and, even 293 
other neonates, as in the present case, are potential reservoirs and routes of entry of 294 
pathogenic organisms associated with nosocomial infections in NICUs.  295 
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Figure legends 445 
Figure 1. Characterization of the strains causing the outbreak and the K1-positive E. 446 
coli counterparts used in this study. Abbreviation: ND, not determined. Bold letters 447 
represent the strains belonging to the outbreak. 448 
Figure 2. Adhesion (A) and invasion (B) assays of E. coli isolates to HBMECs. The 449 
displayed data are the mean ± standard deviation of adhesion and invasion %, 450 
respectively, of at least three independent experiments by duplicate. The strain N38 451 
belonged to the outbreak, whereas N36, N39, N40 and N49 are non-outbreak strains. 452 
Supplementary figure legend 453 
Supplementary Figure 1. C. elegans infection assay of strains N36 (non-outbreak) vs. 454 
N38 (outbreak strain).455 
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Number 
of strain 
Date of 
sepsis 
(day/month) 
Sex 
Gestational 
age (weeks) 
Birth 
Weight (g) 
Age a 
(days) 
Diagnosis Other pathologies Evolution Treatment 
N35 13/04/2013 Female 29.2 1,000 7 b 
Late sepsis   & 
meningitis  
IVHd-Grade II Meningitis and death CTX + AK 
N38 03/05/2013 Female 28 750 12 b 
Late sepsis   & 
meningitis 
Hyaline membrane 
disease+ IVH-Grade II 
Meningitis, 
hydrocephalus and death 
CTX + MEM 
MEM + AK 
N41 31/05/2013 Male 28.2 710 105 
Late sepsis 
& UTI b 
Hyaline membrane disease 
+ Inguinal hernia 
Good evolution CTX 
N43 09/07/2013 Female 25.2 776 96 
Late sepsis   & 
meningitis 
Hyaline membrane 
disease+ IVH-Grade III + 
Necrotizing enterocolitis 
Hydrocephalus MEM + CIP 
N47 08/08/2013 Male 26.3 900 11b 
Late sepsis   & 
meningitis 
Hyaline membrane disease 
+ central nervous system 
hemorrhage 
Meningitis and death MEM + CIP 
N48 15/08/2013 Female 27.3 870 23 Late sepsis   & Hyaline membrane disease Hydrocephalus MEM + CIP 
Table 1
a Age when the neonate developed sepsis 
b Patient died 
Abbreviations: UTI, Urinary Tract Infection; IVH, Intraventricular hemorrhage; CTX, Cefotaxime; AK, Amikacin; MEM, Meropenem; CIP, 
Ciprofloxacin. 
Table 1. Characteristics of the neonates belonging to the outbreak. 
meningitis 
Grey color, length of stay at the hospital. Dark grey color, date of sepsis. 
aDate of admission to the NICU in the Hospital Clinic, Barcelona 
bPatient died 
cDate of discharge  
Abbreviations: F, February; M, March; A, April; My, May; J, June; JL, July; AG, August; S, September. 
Table 2. Temporal distribution of the cases belonging to the outbreak. 
 
 
  Month (Year 2013) 
Case 
Date of 
birth 
(day/ 
month) 
F M A My J JL AG S 
N35 7/4   7/4 a 13/4 29/4b   
N38 21/4  21/4a 3/5 22/5 b   
N41 15/2  15/2 a  22/4c  30/5 a 31/5 11/6c  
N43 4/4   4/4 a    9/7  26/8c  
N47 28/7  28/7a 8/8  4/9b 
N48 22/7  22/7a 15/8 27/9c 
Table 2
Table 3. Transcriptional values of representative genes overexpressed in N38 (outbreak 
strain) comparing to N36 (non-outbreak strain). Fold change indicates the ratio between 
the levels of expression in N38 and N36.  Only statistically significant results (p < 0.05) 
are shown. 
Locus tag Gene Description 
Fold change 
(N38/N36) 
LIPOPOLYSACCHARIDE BIOSYNTHESIS 
CE10_4186 
 
rfaI 
 
UDP-glucose:(Glucosyl) LPS alpha1. 3-
glucosyltransferase 
266.39 
 
CE10_4181 
 
rfaL 
 
O-antigen ligase 
 
156.4 
 
CE10_4187 
 
rfaP kinase that phosphorylates core heptose of 
lipopolysaccharide 
5.28 
 
CE10_4184 
 
rfaY 
 
lipopolysaccharide core biosynthesis protein 
 
195.615 
 
CE10_4185 
 
waaT 
 
UDP-galactose:(Glucosyl) LPS alpha1. 2-
galactosyltransferase 
143.05 
 
CE10_4182 
 
waaV 
 
putative beta1.3-glucosyltransferase 
 
59.46 
 
CE10_4183 
 
waaW 
 
UDP-galactose:(Galactosyl) LPS alpha1. 2-
galactosyltransferase 
216.03 
 
VIRULENCE 
CE10_3431 
 
papI1 
 
pap operon regulatory protein PapI 
 
46.80 
 
FLAGELLAR ASSEMBLY 
CE10_2209 
 
fliD 
 
flagellar filament capping protein 
 
23.96 
 
CE10_2208 
 
fliC 
 
flagellar filament structural protein (flagellin) 
 
5.40 
 
Table 3
Table 4. Fold change of gene expression of N36, N39, N40, and N49 (all non-outbreak 
strains) versus the outbreak strain N38. NE, not expressed. 
Gene Description/function N36 N39 N40 N49 
neuC UDP-N-acetylglucosamine 2-epimerase -1.462 -1.008 1.31 2.463 
kpsC capsule polysaccharide export protein 1.717 5.198 22.297 18.879 
kpsD polysialic acid transport protein 1.103 -8.684* -1.162 -5.858* 
fimD Type-1 fimbria 3.3112* 6.561* -1.3 3.971* 
ompA Outer membrane protein A 1.001 1.652 1.791 9.247** 
aslB VFG associated with meningitis -2.239 2.172 -1.187 4.867 
ibeB VFG associated  with meningitis 2.043 15.144 2.614 5.255 
ibeC VFG associated  with meningitis 4.238** 1.457 3.866* 2.027 
papI1  Pap operon regulatory protein PapI NE** NE** -8.471* NE** 
rfaI UDP-glucose:(Glucosyl) LPS alpha1, 3-
glucosyltransferase 
NE** -4.879 -36.744** -4.568 
rfaL O-antigen ligase NE** -1.092 -4.794** -2.16 
rfaP kinase that phosphorylates core heptose of 
lipopolysaccharide 
-1.338 1.5 -1.187 1.079 
rfaY lipopolysaccharide core biosynthesis 
protein 
NE** 180.403** 47.001** 62.175** 
waaT UDP-galactose:(Glucosyl) LPS alpha1, 2-
galactosyltransferase 
NE 2.46 -1.695 2.031 
waaV putative beta1,3-glucosyltransferase NE** 168.868** 74.456** 136.712** 
waaW UDP-galactose:(Galactosyl) LPS alpha1, 2-
galactosyltransferase 
NE** 156.637** 85.067** 160.839** 
fliD flagellar filament capping protein NE* 108.737 NE NE 
fliC flagellar filament structural protein 
(flagellin) 
NE* 3.764 NE** NE 
Table 4
Bold letters represent genes for which the expression is higher in N38 than in all the 
other strains. 
*p-value<0.05 
**p-value<0.01 
 
 
 
*Bold letter represent the genes present in N38 but absent in the other strains. 
Table 5. Prevalence of virulence factor genes (VFGs) among N38 (outbreak strain) and 
N36, N39, N40 and, N49 (non-outbreak strains). 
Gene Description/function N36 N38 N39 N40 N49 
Toxins 
hlyA hemolysin - + + - - 
cnf1* cytotoxic necrotizing factor - + - - - 
sat1 autotransporter toxin - - - + - 
P- fimbriae 
papA  - - - - + 
papEF  - - - - + 
papC  - - + - - 
Type-1 fimbriae 
fimH  + + + + + 
Type 1-C fimbria 
focG  - - - - - 
S-fimbriae 
sfa/foc*  - + - - - 
sfaS*  - + - - - 
Iron uptake systems 
fyuA yersiniabactin + + + + + 
iutA siderophore + + + + + 
iroN siderophore + + + + + 
iucC aerobactin + + + + + 
Other VFGs associated with virulence 
ibeA  invasion of brain endothelium factor + + + - - 
ibeC invasion of brain endothelium factor + + + + + 
aslA arylsulfatase-like - - + + + 
traJ VFG involved in meningitis + - + + + 
hra* heat-resistant agglutinin - + - - - 
Table 5
Figure 1 Click here to download Figure Figure_1.tif 
Figure 2 Click here to download Figure Figure_2.tif 
Supplemental Digital Content 1. Table. Primers used in Real-Time PCR experiments. 
Gene Primer sequence (5´-3´) (F/R) 
neuC AGGCAGAAAGGCCGTGTTC/CCCTCTGACGATTGCATTTTTT 
kpsC GCCGGAAATACAGCTCTGATAAG/TCCCCGGTCACGATGGT 
kpsD GCGAATGCAGGAAGCACAA/CCACGGTGCGTGCTTTC 
fimD CGCGCGTTGGGATAAAACT/CAAACGGCAGCGGCTTA 
ompA CAGGAGTGATCGCATACTCAACA/ACGACACCGGCGTTTCTC 
aslB CGCCTGGCTGATGAAACG/ATATCGCCGGGAGCATGTAG 
ibeB GTTAAATTACCGGCGGGCTT/GGTCAGGCTGATAGACGGGAA 
ibeC CCAGCGTGGACGCATGA/AGCTCCGGCGTGGTTTC 
rfaI CTGGGCCGGTTATCCAAGT/TCCAGGGCGATGCTTCTTT 
rfaL CAGCTTCCCACGCTACAACA/TTGATGCCAGTAAAGAAGGGAAA 
rfaP ATGCTGCGGGCATTAACC/GCAAGTGCAGCAGGAAATGA 
rfaY ACGGCAGAGCGGAAAGC/CAATACCCAGGTGACGTTCCA 
waaT AAACGCCCCAGAGCTAAATGT/CGCCAGCACCATACAAAAAA 
waaV TTGCGCACGAAAGAATCTACTC/TGAATTTCTTCTTTCCGGTTACCT 
waaW GACGAATTATCCCTGCCAGAAG/GCCACATCATTCCAGCAAGA 
papI_1 GGAGGGAAAACCGCAGAAA/CGTGCCTGATAATCCGTTACC 
fliD TGCCAGCGGCGTAGGT/GGTTGTGATGCCGGTTTTTT 
fliK GCGATGCTGCACAAGATTTTC/GTTGTCTCGCCTGCTAATGCT 
fliC CCATCGACAAATTCCGTTCA/CGCAGAATCCAGACGGTTCT 
Supplemental Digital Content (Including Separate Legend) Click here to download Supplemental Digital Content
(Including Separate Legend) Supplemental Digital
Supplemental Digital Content 2. Table. Primers used to detect the virulence factor 
genes (VFGs) and PAI IIJ96-like domain. 
Gene Primer sequence (5´-3´) (F/R) Reference 
hlyA AACAAGGATAAGCACTGTTCTGGCT/ACCATATA
AGCGGTCATTCCCGTCA 
(1) 
cnf1 AAGATGGAGTTTCCTATGCAGGAG/CATTCAGAG
TCCTGCCCTCATTATT 
(1) 
sat1 ACTGGCGGACTCATGCTGT/AACCCTGTAAGAAG
ACTGAGC 
(1) 
papA ATGGCAGTGGTGTCTTTTGGTG/CGTCCCACCATA
CGTGCTCTTC 
(1) 
papEF GCAACAGCAACGCTGGTTGCATCAT/AGAGAGAG
CCACTCTTATACGGACA 
(1) 
papC GACGGCTGTACTGCAGGGTGTGGCG/ATATCCTT
TCTGCAGGGATGCAATA 
(1) 
fimH CAGCGATGATTTCCAGTTTGTGTG/TGCGTACCAG
CATTAGCAATGTCC 
(2) 
focG CAGCACAGGCAGTGGATACGA/GAATGTCGCCTG
CCCATTGCT 
(1) 
sfa/foc CTCCGGAGAACTGGGTGCATCTTAC/ 
CGGAGGAGTAATTACAAACCTGGCA 
(3) 
sfaS AGAGAGAGCCACTCTTATACGGACA/CCGCCAGC
ATTCCCTGTATTC 
(1) 
hra CAGAAAACAACCGGTATCAG/ACCAAGCATGATG
TCATGAC 
(1) 
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fyuA TGATTAACCCCGCGACGGGAA/CGCAGTAGGCAC
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TACCCACCTGATCGCCATAC 
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 Supplemental Digital Content 3. Figure. Caenorhabditis elegans infection assay of 
strains N36 (non-outbreak) vs. N38 (outbreak strain). 
 Supplemental Digital Content 4. Table. Transcriptional values of representative genes 
differentially expressed in the outbreak strain N38 comparing to the non-outbreak strain 
N36. Fold change indicates the ratio between the levels of expression in N38 and N36.  
Only statistically significant results (p < 0.05) are shown. 
Locus tag Gene Description 
Fold 
change 
(N38/N36) 
CE10_4186 rfaI UDP-glucose:(Glucosyl) LPS alpha1, 3-
glucosyltransferase 
266.39 
CE10_1685 yddB putative porin protein 194.92 
CE10_4183 waaW UDP-galactose:(Galactosyl) LPS alpha1, 2-
galactosyltransferase 
216.03 
CE10_3421 papX HTH-type transcriptional regulator 184.27 
CE10_4184 rfaY lipopolysaccharide core biosynthesis protein 195.61 
CE10_1687 yddA ABC transporter ATP-binding protein 156.87 
CE10_3206 mazF mRNA interferase toxin, antitoxin is MazE 134.06 
CE10_4181 rfaL O-antigen ligase 156.40 
CE10_2290 ibrA immunoglobulin-binding regulator A 100.25 
CE10_4185 waaT UDP-galactose:(Glucosyl) LPS alpha1, 2-
galactosyltransferase 
143.05 
CE10_4203 dinD DNA-damage-inducible protein 86.38 
CE10_3207 mazE antitoxin of the ChpA-ChpR toxin-antitoxin 
system 
58.53 
CE10_4611 tsx2 nucleoside-specific channel-forming protein 
Tsx 
67.25 
CE10_1043 essD2 DLP12 prophage phage lysis protein 56.86 
CE10_1762 celA 6-phospho-beta-glucosidase 49.48 
CE10_4182 waaV putative beta1,3-glucosyltransferase 59.46 
CE10_3431 papI1 pap operon regulatory protein PapI 46.80 
CE10_1496 yciE putative rubrerythrin/ferritin-like metal-binding 
protein 
48.93 
CE10_1684 pqqL putative peptidase 14.08 
CE10_5142 quuQ Qin prophage antitermination protein Q 28.62 
CE10_2292 yaiP2 putative glucosyltransferase 26.38 
CE10_2209 fliD flagellar filament capping protein 23.96 
CE10_1858 ynfF S- and N-oxide reductase, A subunit, 
periplasmic 
23.14 
CE10_4830 eptA putative metal dependent hydrolase 8.59 
CE10_1608 ynbB putative CDP-diglyceride synthase 20.92 
CE10_0326 yaiO1 outer membrane protein 19.33 
CE10_1610 ynbD putative phosphatase inner membrane protein 18.12 
CE10_1857 ynfE putative selenate reductase, periplasmic 17.49 
CE10_2055 ydjK putative transporter 9.27 
CE10_2293 yaiX2 putative nucleotidyl transferase 16.77 
CE10_1460 essD3 DLP12 prophage phage lysis protein 17.38 
CE10_1497 yciF YciF protein 15.58 
CE10_1726 tfaE e14 prophage tail fiber assembly protein 15.21 
CE10_2294 yaiO2 outer membrane protein 14.39 
CE10_1605 ydbC putative oxidoreductase, NAD(P)-binding 
protein 
12.83 
CE10_0327 yaiX1 putative transferase 13.65 
CE10_3139 ascB cryptic 6-phospho-beta-glucosidase 11.19 
CE10_1609 ynbC putative hydrolase 11.59 
CE10_2053 ydjI putative aldolase 6.07 
CE10_2054 ydjJ putative oxidoreductase, Zn-dependent and 
NAD(P)-binding protein 
7.20 
CE10_3180 cysI sulfite reductase, beta subunit, NAD(P)-
binding, heme-binding protein 
10.07 
CE10_4829 basR DNA-binding response regulator in two-
component regulatory system with BasS 
6.10 
CE10_2317 yeeT1 CP4-44 prophage protein 11.12 
CE10_1394 chaA calcium/sodium:proton antiporter 4.04 
CE10_2052 ydjH putative kinase 5.61 
CE10_1692 ydeP putative oxidoreductase 4.20 
CE10_4187 rfaP kinase that phosphorylates core heptose of 
lipopolysaccharide 
5.28 
CE10_3125 srlA PTS system glucitol/sorbitol-specific 
transporter subunit IIC 
6.98 
CE10_3128 srlD sorbitol-6-phosphate dehydrogenase 8.74 
CE10_2208 fliC flagellar filament structural protein (flagellin) 5.40 
CE10_2636 arnB uridine 5'-(beta-1-threo-pentapyranosyl-4-ulose 
diphosphate) aminotransferase, PLP-dependent 
4.85 
CE10_3936 gntT gluconate transporter, high-affinity GNT I 
system 
5.18 
CE10_1045 arrQ1 Qin prophage lysozyme 8.20 
CE10_0595 entB isochorismatase 5.92 
CE10_1693 ydeQ putative fimbrial-like adhesin protein 4.12 
CE10_4851 cadB putative lysine/cadaverine transporter 5.08 
CE10_4389 asnA asparagine synthetase A 3.53 
CE10_0917 lolA chaperone for lipoproteins 4.20 
CE10_2344 ugd UDP-glucose 6-dehydrogenase 5.46 
CE10_5067 uxuB D-mannonate oxidoreductase, NAD-binding 
protein 
4.92 
CE10_1694 ydeR putative fimbrial-like adhesin protein 3.17 
CE10_0143 htrE putative outer membrane usher protein 6.70 
CE10_1435 ompW outer membrane protein W 4.45 
CE10_2638 arnA fused UDP-L-Ara4N formyltransferase/UDP-
GlcA C-4'-decarboxylase 
3.68 
CE10_0328 yaiP1 putative glucosyltransferase 6.56 
CE10_4638 yijD inner membrane protein 3.11 
CE10_2343 cld regulator of length of O-antigen component of 
lipopolysaccharide chains 
4.55 
CE10_1607 ynbA inner membrane protein 6.40 
CE10_3199 scrR Sucrose operon repressor -491.15 
CE10_3662 yhaV toxin of the SohB(PrlF)-YhaV toxin-antitoxin 
system 
-292.77 
CE10_3201 ygcG hypothetical protein -213.97 
CE10_2355 rfbC dTDP-4-deoxyrhamnose-3,5-epimerase -151.44 
CE10_3198 scrB sucrose-6-phosphate hydrolase -78.95 
CE10_3197 scrA PTS system sucrose-specific transporter 
subunit IIBC 
-82.48 
CE10_3661 sohA antitoxin of the SohA(PrlF)-YhaV toxin-
antitoxin system 
-70.09 
CE10_3196 scrY sucrose porin -66.66 
CE10_4290 yicL hypothetical protein -58.63 
CE10_0280 yahA c-di-GMP-specific phosphodiesterase -30.90 
CE10_4540 yihO putative transporter -51.37 
CE10_4548 yihW putative DNA-binding transcriptional regulator -40.77 
CE10_1650 pptA 4-oxalocrotonate tautomerase -33.64 
CE10_4539 ompL outer membrane porin L -31.66 
CE10_4555 yiiF hypothetical protein -25.18 
CE10_3195 scrK aminoimidazole riboside kinase -24.33 
CE10_4542 yihQ alpha-glucosidase -22.06 
CE10_0154 fhuA ferrichrome outer membrane transporter -7.91 
CE10_3807 yhdZ putative amino-acid transporter subunit -9.18 
CE10_1709 yneE hypothetical protein -6.46 
CE10_4544 yihS aldose-ketose isomerase, D-mannose isomerase -10.77 
CE10_2274 yeeN hypothetical protein -8.39 
CE10_4078 bcsB regulator of cellulose synthase, cyclic di-GMP 
binding protein 
-6.72 
CE10_1581 abgT p-aminobenzoyl-glutamate transporter, 
membrane protein 
-6.35 
CE10_4563 frvR putative frv operon regulator, contains a PTS 
EIIA domain 
-9.65 
CE10_3805 yhdX putative amino-acid transporter subunit -6.39 
CE10_1098 efeO inactive ferrous ion transporter EfeUOB -4.71 
CE10_3178 iap aminopeptidase in alkaline phosphatase 
isozyme conversion 
-4.34 
CE10_0355 ykiA hypothetical protein -5.20 
CE10_1526 osmB lipoprotein -5.40 
CE10_3090 ygaC hypothetical protein -5.14 
CE10_0136 panB 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
-4.60 
CE10_2379 wza lipoprotein required for capsular 
polysaccharide translocation through the outer 
membrane 
-7.66 
CE10_3931 yhgA putative transposase -4.15 
CE10_0281 yahB putative DNA-binding transcriptional regulator -3.88 
CE10_2001 ydiY putative outer membrane protein, acid-
inducible 
-4.46 
CE10_0525 arrD1 DLP12 prophage lysozyme -5.63 
CE10_0133 yadD putative transposase -3.35 
CE10_2250 yedZ inner membrane heme subunit for periplasmic 
YedYZ reductase 
-3.76 
CE10_4079 bcsA cellulose synthase, catalytic subunit -4.58 
 Supplemental Digital Content 5. Table. Minimum inhibitory concentrations (µg/ml) 
among N38 (outbreak strain) and N36, N39, N40 and, N49 (non-outbreak strains).  
Abbreviations: AMP, ampicillin; AMC, amoxicillin-clavulanic acid; TZP, piperacillin-
tazobactam; CTX, cefotaxime; MEM, meropenem; TET, tetracycline; SXT, 
trimethoprim-sulfamethoxazole; GEN,gentamicin; AK, amikacin; KAN, kanamycin; 
NA, nalidixic acid; CIP, ciprofloxacin, and FOF, fosfomycin. 
 
 
 Antimicrobial agents 
No. of 
Strain 
AMP AMC TZP CTX MEM TET SXT GEN AK KAN NA CIP FOF 
N36 3 8 1.5 0.5 0.012 2 1 0.5 1.5 2 3 0.012 0.50 
N38 >256 16 2 0.5 0.016 128 0.006 4 8 6 3 0.012 192 
N39 3 6 1 0.5 0.012 2 0.094 0.5 2 3 128 0.19 0.75 
N40 >256 8 1 0.5 0.012 64 >32 48 2 6 >256 >256 0.5 
N49 >256 12 1 0.38 0.006 >256 >32 0.5 2 1.5 3 0.006 1 
